Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

Share Price is delayed by 15 minutes
Get Live Data
32.50    0.00 (0.00%)
Bid:
32.00
Ask:
33.00
Spread: 1.00 (3.125%)
Market Cap: £19.28m
KRM Live PriceLast checked at - London Stock Exchange

Intraday Krm22 Plc Share Chart

Trading Update

12 Jan 2021 07:00

RNS Number : 3137L
KRM22 PLC
12 January 2021
 

KRM22 plc

 

("KRM22", the "Group" or the "Company")

 

Trading update

 

KRM22 plc (AIM: KRM.L) announces a trading update for the 12 month period to 31 December 2020 ("FY2020").

 

The Company continued to make good progress during the year, winning top tier institutions as customers. Increases in new contracted ARR have been offset by churn in its existing customer base as firms inevitably adjusted to the new trading environment as a result of COVID-19.

For FY2020 the Group expects to report:

· A significantly improved adjusted EBITDA loss of approximately £0.1m (FY2019: loss of £3.1m)

· Revenue of approximately £4.6m (FY2019: £4.1m)

· Gross cash as at 31 December 2020 was £2.0m (FY2019: £1.1m)

· ARR at 31 December 2020 of £4.3m (FY2019: £4.3m) at the 2020 constant exchange rate (£4.1m at current rates)

o New contracted ARR in FY2020 of £0.8m, reflecting a gross organic growth rate of 19%

The Company has a near term pipeline of a further £0.5m ARR of deals which are in final contract negotiations and which are expected to be signed in Q1 2021. In addition to this the Company has a strong pipeline of opportunities for 2021. Whilst the net contracted ARR has remained static at £4.3m, the new contracted ARR in FY2020 is made up of higher quality customers. Sterling's continued strengthening against the US dollar has had a negative impact on contracted ARR as described above.

The Board is pleased to note that the Company signed contracts with two, tier one banks in the second half of the year. One of the contracts covered a pre implementation phase for the At Trade Market Risk product, which will lead to significant contracted ARR in 2021. The second contract for £0.2m ARR was signed in December for the Pre Trade Market Risk product.

The total new contracted ARR in FY2020 of £0.8m is spread across different risk domains including £0.5m on Market Risk products, £0.2m on Compliance Risk products and £0.1m on Enterprise Risk products. The new contracted ARR is derived from six new customers, including top tier institutions, and two existing customers. The sale of new risk products to existing customers and the signing of a contract for a suite of products to a UK Brokerage firm, as referred to in the announcement of August 2020, demonstrates KRM22's ability to simplify the cost and complexity of risk management through technology delivered on one platform as a one-stop service.

The total churn in FY2020 for institutional customers was £0.8m which included some legacy customers acquired through previous acquisitions. In addition, a number of our trader customers were lost as they were unable to trade due to the CME floor being closed as a result of the COVID-19 lockdown. The overall level of churn in FY2020 has been significantly higher than we have experienced historically or was expected but management expects this to stabilise in 2021. We settled the disputed contract referred to in previous announcements in December. While in our view our case was strong, we decided that the agreed settlement was pragmatically the right action to avoid the uncertainty, distraction and cost of litigation. The balance has been written off in FY2020.

Costs continue to be under tight control however we have started to phase back the voluntary salary sacrifices in Q4 2020, with phased full reinstatement starting in January 2021 and expected to complete in January 2022.

The Group's net debt as at 31 December 2020 was £1.0m (31 December 2019: £0.9m) and included cash of £2.0m and gross debt, relating to the three-year convertible loan that was signed with Kestrel Partners LLP in September 2020, of £3.0m (31 December 2019: cash of £1.1m and gross debt of £2.0m).

The Company expects to report full year results for the year to 31 December 2020 on 16 March 2021.

 

Keith Todd, Executive Chairman and CEO at KRM22, commented: 'The year has been challenging but we have made good progress in improving the quality of our customer revenue base with increased cross sale opportunities and a significant reduction in our adjusted EBITDA loss. The strengthened balance sheet provides a sound financial base for 2021.

Our Global Risk Platform has matured well and has an increasing positive impact in creating new sales opportunities.

The KRM22 business is in a much stronger position than a year ago and is well placed for growth in 2021.'

 

For further information please contact:

KRM22 plc InvestorRelations@krm22.com

Keith Todd CBE, Executive Chairman and CEO

Kim Suter, CFO

 

finnCap Ltd (Nominated Adviser and Sole Broker) +44 (0)20 7220 0500

Carl Holmes / Kate Bannatyne / Matthew Radley

Alice Lane / Sunila de Silva (ECM)

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' regulatory, market, technology and operations risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimise risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com.

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFFFAFEFSEDF
Date   Source Headline
26th May 20263:24 pmRNSHolding(s) in Company
26th May 20262:25 pmRNSHolding(s) in Company
22nd May 20267:00 amRNSDirector Dealings
20th May 202611:19 amRNSDirector Dealings
20th May 20267:00 amRNSNotice of AGM and Posting of Annual Report
13th May 20267:00 amRNSFinal Results
29th Jan 20267:00 amRNSTrading Update
7th Jan 20267:00 amRNSAppointment of Director
20th Nov 20254:12 pmRNSTR-1
11th Nov 20257:00 amRNSIssue of Equity
10th Nov 20259:28 amRNSHolding(s) in Company
5th Nov 20251:05 pmRNSResult of GM
15th Oct 20257:00 amRNSResult of Placing
14th Oct 20254:50 pmRNSProposed Placing and Subscription
17th Sep 20257:00 amRNSInterim Results
7th Aug 20257:00 amRNSTrading Update
21st Jul 20257:00 amRNSIssue of Equity
27th Jun 20252:10 pmRNSResult of AGM
6th Jun 20257:00 amRNSDirector Dealing
2nd Jun 20257:00 amRNSIssue of Restricted Stock Units
30th May 20257:00 amRNSNotice of AGM and Posting of Annual Report
21st May 20257:00 amRNSDirector Dealing
19th May 20257:00 amRNSFinal Results
29th Apr 20257:00 amRNSFacility Amendment
7th Apr 20257:00 amRNSNew Customer Contracts
1st Apr 20257:00 amRNSFacility Amendment
18th Mar 20257:00 amRNSIssue of Equity
4th Mar 20257:00 amRNSNew Customer Contract
13th Feb 20255:00 pmRNSDirector Dealing
22nd Jan 20257:00 amRNSTrading Update
10th Jan 20257:00 amRNSIssue of Equity
23rd Dec 20247:00 amRNSLoan Facility Amendment
15th Oct 20247:00 amRNSIssue of Equity
25th Sep 20247:00 amRNSInterim Results
3rd Sep 20247:00 amRNSChange of Registered Office
29th Aug 20247:00 amRNSNew Customer Contract
22nd Aug 202410:00 amRNSGrant of Options and Director/PDMR Shareholding
19th Aug 20247:00 amRNSIssue of Equity
18th Jul 20247:00 amRNSHalf Year Trading Update
21st Jun 202412:49 pmRNSResult of AGM
29th May 20247:00 amRNSNotice of AGM and Posting of Annual Report
22nd May 20247:00 amRNSFinal Results
16th Apr 20247:00 amRNSDirector Dealings
15th Apr 20247:00 amRNSNew Customer Contract
10th Apr 20247:00 amRNSIssue of Equity
7th Mar 20247:00 amRNSBoard Changes
21st Feb 20247:00 amRNSTrading Update
1st Dec 20237:00 amRNSIssue of Restricted Stock Units
26th Sep 20237:00 amRNSInterim Results
27th Jul 202311:48 amRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.